Kowal Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.2M | Buy |
16,186
+1,180
| +8% | +$233K | 0.59% | 25 |
|
|
2024
Q2 | $2.57M | Buy |
15,006
+671
| +5% | +$115K | 0.51% | 29 |
|
|
2024
Q1 | $2.61M | Buy |
14,335
+1,671
| +13% | +$304K | 0.56% | 23 |
|
|
2023
Q4 | $1.96M | Buy |
12,664
+949
| +8% | +$147K | 0.46% | 32 |
|
|
2023
Q3 | $1.75M | Sell |
11,715
-502
| -4% | -$74.8K | 0.47% | 27 |
|
|
2023
Q2 | $1.65M | Buy |
12,217
+352
| +3% | +$47.4K | 0.44% | 29 |
|
|
2023
Q1 | $1.89M | Buy |
11,865
+248
| +2% | +$39.5K | 0.54% | 26 |
|
|
2022
Q4 | $1.88M | Buy |
11,617
+171
| +1% | +$27.6K | 0.56% | 26 |
|
|
2022
Q3 | $1.54M | Buy |
11,446
+252
| +2% | +$33.8K | 0.52% | 24 |
|
|
2022
Q2 | $1.72M | Sell |
11,194
-122
| -1% | -$18.7K | 0.56% | 19 |
|
|
2022
Q1 | $1.83M | Buy |
11,316
+7,360
| +186% | +$1.19M | 0.56% | 15 |
|
|
2021
Q4 | $536K | Buy |
3,956
+229
| +6% | +$31K | 0.16% | 51 |
|
|
2021
Q3 | $402K | Sell |
3,727
-705
| -16% | -$76K | 0.13% | 62 |
|
|
2021
Q2 | $499K | Buy |
4,432
+43
| +1% | +$4.84K | 0.18% | 49 |
|
|
2021
Q1 | $475K | Buy |
4,389
+147
| +3% | +$15.9K | 0.19% | 47 |
|
|
2020
Q4 | $466K | Buy |
+4,242
| New | +$466K | 0.22% | 48 |
|